Latest It Compliance News

Lucapa Diamond Company Limited’s shares remain suspended following the appointment of voluntary administrators, highlighting severe financial distress and regulatory breaches.

Constellation Resources Limited is raising approximately $2.52 million through a non-renounceable entitlement offer priced at $0.12 per share, aiming to fund exploration projects in Western Australia and support general working capital.

Unith Ltd has responded to an ASX price query following unusual trading activity, denying undisclosed information and pointing to a successful recent roadshow as a potential factor.

Bendigo and Adelaide Bank reported a slight dip in its Common Equity Tier 1 ratio to 10.83% for the March 2025 quarter, reflecting dividend payments and increased residential lending. Despite this, the bank sustained robust liquidity and funding metrics well above regulatory minimums.

Fintech Chain Limited has applied to delist from the ASX, citing low valuation, poor liquidity, and high costs, aiming to unlock growth capital in China and the US.

The Australian Wealth Advisors Group has deepened its Equity Partnership Scheme with strategic stakes in Oneledger and B2B Invest, setting up royalty revenue streams that align with its expansion in financial services.

EBR Systems has announced a fully underwritten A$55.9 million capital raise alongside a Security Purchase Plan to fund the commercial rollout of its FDA-approved WiSE CRT System, targeting a US$3.6 billion market opportunity in cardiac resynchronization therapy.

West Wits Mining Limited (WWI) has addressed recent spikes in its share price and trading volume, linking the activity to funding developments, a strong gold price, and positive market commentary.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

OD6 Metals has secured regulatory approval to launch an 18-hole, 5,000-metre drilling program at its Gulf Creek Copper Project, targeting promising repeat mineral structures. A further 7-hole deep drilling phase awaits approval, potentially expanding exploration near historic high-grade copper zones.

AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208 million for the year ending March 2025, but net profit fell 23%, prompting a modest final dividend declaration.

Carbine Resources Limited has announced a pro-rata entitlement offer aiming to raise approximately $1.1 million to fund exploration and working capital. The offer includes broker options subject to shareholder approval and targets shareholders in select jurisdictions.